40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.07%
Negative revenue growth while MTDR stands at 22.88%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.51%
Negative gross profit growth while MTDR is at 10.69%. Joel Greenblatt would examine cost competitiveness or demand decline.
-37.21%
Negative EBIT growth while MTDR is at 10.31%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.21%
Negative operating income growth while MTDR is at 10.31%. Joel Greenblatt would press for urgent turnaround measures.
133.62%
Net income growth above 1.5x MTDR's 11.39%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
131.25%
EPS growth above 1.5x MTDR's 8.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
131.25%
Diluted EPS growth above 1.5x MTDR's 4.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.96%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-18.66%
Negative OCF growth while MTDR is at 155.22%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-52.08%
Negative FCF growth while MTDR is at 1.88%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-27.47%
Negative 10Y revenue/share CAGR while MTDR stands at 652.63%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.22%
Negative 5Y CAGR while MTDR stands at 652.63%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-20.55%
Negative 3Y CAGR while MTDR stands at 171.47%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
19.51%
10Y OCF/share CAGR under 50% of MTDR's 106.61%. Michael Burry would worry about a persistent underperformance in cash creation.
-60.24%
Negative 5Y OCF/share CAGR while MTDR is at 106.61%. Joel Greenblatt would question the firm’s operational model or cost structure.
-20.86%
Negative 3Y OCF/share CAGR while MTDR stands at 647.12%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
34.57%
Below 50% of MTDR's 1256.10%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
14.92%
Below 50% of MTDR's 1256.10%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
53.00%
3Y net income/share CAGR similar to MTDR's 58.77%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-25.90%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.54%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-60.18%
Negative 3Y equity/share growth while MTDR is at 86.89%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
34.87%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-83.16%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-66.20%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-3.69%
Firm’s AR is declining while MTDR shows 16.26%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.28%
Inventory is declining while MTDR stands at 3.36%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.90%
Asset growth at 75-90% of MTDR's 10.93%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
32.38%
1.25-1.5x MTDR's 28.67%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-1.51%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.53%
SG&A declining or stable vs. MTDR's 12.20%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.